Donate
|
Resource Hub
Who we are
Our Strategy
Strategy Extension
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Where We Work
Poliovirus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Surveillance
Supplementary Immunization
Outbreak Preparedness & Response
Containment
Routine Immunization
Gender Mainstreaming
Polio Gender Champions
Integration
Environmental Safeguarding
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Donors & Financing
Financial Resource Requirements
GPEI Budget 2024
GPEI Budget 2023
GPEI Budget 2022
2020-2024 outbreak budget monitoring
Expenditure Information
Historical Contributions
News
Media Centre
Take Action
Who we are
Our Strategy
Strategy Extension
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Where We Work
Poliovirus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Surveillance
Supplementary Immunization
Outbreak Preparedness & Response
Containment
Routine Immunization
Gender Mainstreaming
Polio Gender Champions
Integration
Environmental Safeguarding
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Donors & Financing
Financial Resource Requirements
GPEI Budget 2024
GPEI Budget 2023
GPEI Budget 2022
2020-2024 outbreak budget monitoring
Expenditure Information
Historical Contributions
News
Media Centre
Take Action
Choose the resource category and filter for results
Resources for Polio Eradicators
Containment
- Global Action Plan for Poliovirus Containment (GAP)
- Containment Certification Scheme (CCS)
- Potentially Infectious Material (PIM) guidance
- Exposure guidance
GPEI Tools, Protocols and Guidelines
- Polio Post-Certification Strategy
- Outbreak preparedness and response
- Vaccines and logistics
- Surveillance
- Supplementary Immunization Activities (SIA)
- Webinars and E-Learning
- Communication for Eradication Strategies
- Strategies
Policy & Reports
Advisory Committee on Poliomyelitis Eradication
AFRO Reports
Annual Reports
Containment Advisory Group
Declarations and Resolutions
Expenditure Reports
Financial Reports
- Non-FRR Reports
GACVS sub-committee on novel OPV2 safety
Gender Mainstreaming
Global Certification Commission
Global Polio Laboratory Network Reports
IMB Reports
Polio and Climate Change
Polio Newsletter
Polio Oversight Board (POB) Documents
Polio Oversight Board (POB) Letters
Polio Oversight Board (POB) Meeting Minutes
Polio Partners Group
Regional Certification Commission
Reports to WHO Governing Bodies
Semi-Annual Status Reports
Technical Advisory Groups
TIMB Reports
WHO Weekly Epidemiological Record
Multimedia
Photos
Videos
Sort by
Newest First
Oldest First
Filter
Reset
Resource Hub
WER: Report of the 4th joint meeting of the WHO Global Advisory Committee on Vaccine Safety and the Advisory Committee on Safety of Medicinal Products, 12–14 November 2024 | 7 March 2025, No. 10, vol. 100, pp. 75–86
Historical Contributions 1988 -2022
WER: Notes from the field: Detection of vaccine derived poliovirus type 2 (VDPV2) in wastewater in 5 European countries, September–December 2024 | 7 February 2025, Vol. 100, No. 06, pp. 41–44
Polio News 2025 – English
January
|
February
|
Polio News 2025 – Français
Janvier
|
Février
|
GPSAP: Outputs from polio surveillance subject matter expert work groups – risks and risk mitigation strategies
Polio Vaccine Security Framework
Global Polio Surveillance Action Plan 2025–2026 (pre-publication version)
Annual Consultation between the GPEI and polio vaccine manufacturers, National Authorities for Containment and National Regulatory Authorities
WER: Progress towards poliomyelitis eradication – Afghanistan, January 2023–September 2024 | 13 December 2024, Vol. 99, No. 50, pp. 745–754
156th Executive Board – 2025 | Poliomyelitis
arabic
|
chinese
|
english
|
french
|
russian
|
spanish
|
WER: Meeting of the Strategic Advisory Group of Experts on Immunization, September 2024: conclusions and recommendations | 6 December 2024, Vol. 99, No. 49, pp. 719–740
Polio eradication strategy 2022-2026: delivering on a promise, extension to 2029
GPEI Multi-Year Budget Explainer 2022-2029
7th Report – October 2024
1
2
3
…
43
